Germany
Japan
United Kingdom
China
Cd200r1 rat monoclonal antibody, clone OX-110, Low Endotoxin
| Applications | FC |
| Reactivities | Mouse |
Primary Antibodies
Download
Cd200r1 rat monoclonal antibody, clone OX-110, Purified
| Applications | FC |
| Reactivities | Mouse |
Cd200r1 rat monoclonal antibody, clone OX-110, Purified
| Applications | FC |
| Reactivities | Mouse |
Cd200r1 rat monoclonal antibody, clone OX-110, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
CD49e / ITGA5 rat monoclonal antibody, clone MFR5 (5H10), FITC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | FITC |
CD52 rat monoclonal antibody, clone YTH34.5, FITC
| Applications | FC |
| Reactivities | Human, Monkey |
| Conjugation | FITC |
CD52 rat monoclonal antibody, clone YTH34.5, PE
| Applications | FC |
| Reactivities | Human, Monkey, Rhesus Monkey |
| Conjugation | PE |
CD11b rat monoclonal antibody, clone 5C6, FITC
| Applications | FC |
| Reactivities | Human, Mouse |
| Conjugation | FITC |
CD11b rat monoclonal antibody, clone 5C6, PE
| Applications | FC |
| Reactivities | Human, Mouse |
| Conjugation | PE |
HLA Class II DR rat monoclonal antibody, clone YE2/36-HLK, FITC
| Applications | FC |
| Reactivities | Human, Mouse |
| Conjugation | FITC |
HLA Class II DR rat monoclonal antibody, clone YD1/63.4.10, FITC
| Applications | FC |
| Reactivities | Human |
| Conjugation | FITC |
HLA Class II DR rat monoclonal antibody, clone YD1/63.4.10, PE
| Applications | FC |
| Reactivities | Human |
| Conjugation | PE |
TNFSF18 / AITRL rat monoclonal antibody, clone YGL386, Purified
| Applications | FC |
| Reactivities | Mouse |
Dpp4 rat monoclonal antibody, clone H207-1082, Biotin
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Biotin |
Dpp4 rat monoclonal antibody, clone H207-1082, FITC
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | FITC |
Dpp4 rat monoclonal antibody, clone H207-1082, PE
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | PE |
Lag3 rat monoclonal antibody, clone C9B7W, Purified
| Applications | FC |
| Reactivities | Mouse |
Lag3 rat monoclonal antibody, clone C9B7W, Purified
| Applications | FC |
| Reactivities | Mouse |
CD4 rat monoclonal antibody, clone YKIX302.9, FITC
| Applications | FC |
| Reactivities | Canine |
| Conjugation | FITC |
CD4 rat monoclonal antibody, clone YKIX302.9, PE
| Applications | FC |
| Reactivities | Canine |
| Conjugation | PE |
CD5 rat monoclonal antibody, clone YKIX322.3, FITC
| Applications | FC |
| Reactivities | Canine |
| Conjugation | FITC |
CD5 rat monoclonal antibody, clone YKIX322.3, PE
| Applications | FC |
| Reactivities | Canine |
| Conjugation | PE |
CD8A rat monoclonal antibody, clone YCATE55.9, FITC
| Applications | FC |
| Reactivities | Canine |
| Conjugation | FITC |
CD8A rat monoclonal antibody, clone YCATE55.9, PE
| Applications | FC |
| Reactivities | Canine |
| Conjugation | PE |
CD45 rat monoclonal antibody, clone YKIX716.13, Biotin
| Applications | FC |
| Reactivities | Canine |
| Conjugation | Biotin |
CD45 rat monoclonal antibody, clone YKIX716.13, FITC
| Applications | FC |
| Reactivities | Canine |
| Conjugation | FITC |
CD45 rat monoclonal antibody, clone YKIX716.13, PE
| Applications | FC |
| Reactivities | Canine |
| Conjugation | PE |
CD45 (CD45R) rat monoclonal antibody, clone YKIX753.22.2, FITC
| Applications | FC |
| Reactivities | Canine |
| Conjugation | FITC |
CD45 (CD45R) rat monoclonal antibody, clone YKIX753.22.2, PE
| Applications | FC |
| Reactivities | Canine |
| Conjugation | PE |
MHC Class II rat monoclonal antibody, clone YKIX334.2, FITC
| Applications | FC |
| Reactivities | Canine |
| Conjugation | FITC |
Rat anti-PTPRC (CD45) monoclonal antibody
| Applications | IP |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Rat monoclonal anti-MIP-3a antibody
| Applications | WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Rat monoclonal Anti-Mouse MIP-3a (RAT) Biotin Conjugated antibody
| Applications | WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Rat Anti-Mouse CD197 (CCR7) Purified (100 ug)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Rat Anti-Mouse CD160 Purified (50 ug)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Rat Anti-Mouse CD180 (RP105) Purified (50 ug)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Rat Anti-Mouse CD2 Purified (100 ug)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Rat Anti-Mouse CD244.2 (2B4) Purified (100 ug)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Rat Anti-Mouse CD4 Purified (100 ug)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Rat Anti-Mouse CD4 Purified (100 ug)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Rat Anti-Human/Mouse CD44 Purified (100 ug)
| Applications | FC |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Rat Anti-Mouse CD5 Purified (100 ug)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Rat Anti-Mouse CD70 Purified (100 ug)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Rat Anti-Mouse CD86 (B7-2) Purified (100 ug)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Rat Anti-Human CMKLR1 Purified (25 ug)
| Reactivities | Human |
| Conjugation | Unconjugated |
Rat Anti-Human CD115 (c-fms) Purified (25 ug)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rat Anti-Mouse CD115 (c-fms) Purified (50 ug)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Rat Anti-Mouse EBI3 (IL-27 subunit) Purified (25 ug)
| Applications | WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Rat Anti-Human VEGF Receptor 1 (Flt1) Purified (25 ug)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Antibody Hosts
- Rat
Clonalities
- Monoclonal
Filter by
Target Symbol
- ALK (50)
- MKI67 (45)
- CD86 (18)
- CD8A (14)
- BRDU (13)
- ADGRE1 (10)
- IL2RA (10)
- IDU (9)
- ACIDIC CK (8)
- EBI3 (8)
- ITGB7 (8)
- TFRC (8)
- THY1 (8)
- HAVCR2 (7)
- KIT (7)
- LY6A (7)
- CD8B1 (6)
- IL10 (6)
- IL4 (6)
- NIPBL (6)
- RAB11B (6)
- CD4 (5)
- CD5 (5)
- PTPRC (5)
- C5AR1 (4)
- CD80 (4)
- CD9 (4)
- CLASP1 (4)
- FITC (4)
- GLB1 (4)
- IL6 (4)
- KLRD1 (4)
- TCP1 (4)
- AHSA1 (3)
- CBFA2T2 (3)
- CCR7 (3)
- CD226 (3)
- CD274 (3)
- CD44 (3)
- CMKLR1 (3)
- CSF1R (3)
- IL2 (3)
- ITGA4 (3)
- ITGAM (3)
- ITGAV (3)
- LGI4 (3)
- LYL1 (3)
- MAPRE1 (3)
- MAPRE2 (3)
- MAPRE3 (3)
- PDCD1 (3)
- PDCD1LG2 (3)
- PECAM1 (3)
- RAB6B (3)
- CCL20 (2)
- CCRL2 (2)
- CD2 (2)
- CD3E (2)
- CD40 (2)
- CD52 (2)
- CD70 (2)
- ENG (2)
- FLT3 (2)
- H2-D1 (2)
- HSF1 (2)
- HSF2 (2)
- IBSP (2)
- IDH1-MUTANT (2)
- IFNGR2 (2)
- IL2RB (2)
- ITGB4 (2)
- KLRA2 (2)
- KLRB1A (2)
- KLRB1B (2)
- LAMP2 (2)
- LY6G (2)
- MHC I (2)
- SELL (2)
- SIGLEC1 (2)
- TIMD4 (2)
- TLR9 (2)
- TNFSF11 (2)
- TNFSF18 (2)
- TNFSF9 (2)
- TUBA1B (2)
- ADIPOQ (1)
- AKT2 (1)
- ANPEP (1)
- B3GALT5 (1)
- BCL11B (1)
- BID (1)
- BST1 (1)
- CCR9 (1)
- CCT2 (1)
- CD16 (FCGR3A) (1)
- CD160 (1)
- CD180 (1)
- CD19 (1)
- CD200 (1)
- CD209 (1)
Reactivities
- Mouse (310)
- Human (210)
- Rat (76)
- Sheep (9)
- Hamster (7)
- Rabbit (7)
- Canine (6)
- Monkey (6)
- Dog (5)
- Feline (5)
- Porcine (5)
- Bovine (4)
- Escherichia coli (4)
- Guinea Pig (4)
- Pig (4)
- Chicken (3)
- Cow (2)
- C. elegans (1)
- Chimpanzee (1)
- Drosophila melanogaster (1)
- Goat (1)
- Horse (1)
- Mammalian (1)
- Primate (1)
- Saccharomyces cerevisiae (1)
- Xenopus (1)
- Yeast (1)
- Zebrafish (1)
Applications
Isotypes
Conjugates
Knockout (KO) Validation
Modifications
- This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. (12)
- This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. (2)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created to reduce immunogenicity during in vivo applications. (1)
- This reformatted antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Assay Platforms
Families
- Druggable Genome (156)
- ES Cell Differentiation/IPS (60)
- Protein Kinase (53)
- Transmembrane (25)
- Secreted Protein (24)
- Transcription Factors (10)
- GPCR (6)
- Adult stem cells (4)
- Embryonic stem cells (3)
- Induced pluripotent stem cells (2)
- Stem cell relevant signaling - JAK/STAT signaling pathway (2)
- Cancer stem cells (1)
- Phosphatase (1)
- Stem cell - Pluripotency (1)
- Stem cell relevant signaling - DSL/Notch pathway (1)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (1)
- Stem cell relevant signaling - Wnt Signaling pathway (1)
Pathways
- Cytokine-cytokine receptor interaction (13)
- Jak-STAT signaling pathway (11)
- Cell adhesion molecules (CAMs) (10)
- Focal adhesion (10)
- Hematopoietic cell lineage (10)
- Pathways in cancer (10)
- ECM-receptor interaction (9)
- Hypertrophic cardiomyopathy (HCM) (9)
- T cell receptor signaling pathway (9)
- Dilated cardiomyopathy (7)
- Toll-like receptor signaling pathway (7)
- Allograft rejection (6)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (6)
- Asthma (6)
- Regulation of actin cytoskeleton (6)
- Autoimmune thyroid disease (5)
- Complement and coagulation cascades (5)
- Small cell lung cancer (5)
- Systemic lupus erythematosus (5)
- Fc epsilon RI signaling pathway (4)
- NOD-like receptor signaling pathway (4)
- Neuroactive ligand-receptor interaction (4)
- Pathogenic Escherichia coli infection (4)
- Apoptosis (3)
- Gap junction (3)
- Graft-versus-host disease (3)
- MAPK signaling pathway (3)
- Prion diseases (3)
- Acute myeloid leukemia (2)
- Adipocytokine signaling pathway (2)
- Alzheimer's disease (2)
- Amyotrophic lateral sclerosis (ALS) (2)
- Antigen processing and presentation (2)
- Chemokine signaling pathway (2)
- Chronic myeloid leukemia (2)
- Colorectal cancer (2)
- Cytosolic DNA-sensing pathway (2)
- Endocytosis (2)
- Endometrial cancer (2)
- ErbB signaling pathway (2)
- Fc gamma R-mediated phagocytosis (2)
- Leukocyte transendothelial migration (2)
- Natural killer cell mediated cytotoxicity (2)
- Primary immunodeficiency (2)
- Prostate cancer (2)
- TGF-beta signaling pathway (2)
- B cell receptor signaling pathway (1)
- Bladder cancer (1)
- Cell cycle (1)
- Glioma (1)
- Insulin signaling pathway (1)
- Melanogenesis (1)
- Melanoma (1)
- Neurotrophin signaling pathway (1)
- Non-small cell lung cancer (1)
- Pancreatic cancer (1)
- Progesterone-mediated oocyte maturation (1)
- RIG-I-like receptor signaling pathway (1)
- Renal cell carcinoma (1)
- Thyroid cancer (1)
- Tight junction (1)
- Type I diabetes mellitus (1)
- Type II diabetes mellitus (1)
- VEGF signaling pathway (1)
- Viral myocarditis (1)
- Wnt signaling pathway (1)
- mTOR signaling pathway (1)
- p53 signaling pathway (1)